Biodexa Pharmaceuticals PLC Unsponsored ADR

Biodexa Pharmaceuticals PLC Unsponsored ADR’s revenue for fiscal 2023 (year ended December 2023) was $473,900.00, down 45.2% from fiscal 2022.

0.46 0.03 +6.98%

Follow BDRX

Alert me

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+8 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(35.18)	(34.69)	(33.54)	(33.64)
Capital Expenditures Full definition →		(0.10)	(0.05)	(0.02)	0.00
Other line items
Cash ROIC Full definition →		(256.85%)	(162.59%)	(127.17%)	(195.19%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		—	0.00%	—	0.00%
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.52	4.15	0.76	32.35
Capex/Depreciation Full definition →		(0.09)	(0.04)	(0.02)	0.00
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Columns are period end dates